PYC.AX · PYC THERAPEUTICS LIMITED
Australia · RS rating 86 · As of 2026-10-14
| Price | 1.98 AUD |
|---|---|
| 1-day change | -7.5% |
| RS rating (overall / 1M / 3M / 12M) | 86 / 27 / 87 / 91 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 38 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +32.0% |
| Market cap (USD) | $1.7B |